-
1 Comment
Hainan Shuangcheng Pharmaceuticals Co., Ltd is currently in a long term downtrend where the price is trading 3.9% below its 200 day moving average.
From a valuation standpoint, the stock is 35.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.2.
Hainan Shuangcheng Pharmaceuticals Co., Ltd's total revenue sank by 0.9% to $76M since the same quarter in the previous year.
Its net income has dropped by 118.6% to $-9M since the same quarter in the previous year.
Finally, its free cash flow grew by 90.9% to $15M since the same quarter in the previous year.
Based on the above factors, Hainan Shuangcheng Pharmaceuticals Co., Ltd gets an overall score of 2/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100001K63 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Beta | 0.47 |
|---|---|
| Target Price | None |
| PE Ratio | 108.75 |
| Market Cap | 4B |
| Dividend Yield | None |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. engages in research and development, production, and sale of pharmaceutical injections, solid preparations, and raw materials in China and internationally. The company offers products for oncology and immune, alimentary canal, heart and cerebral, and vessels and metabolism. It also provides Bivalirudin, Epitifibatide, and Thymalfaxin for injection; Pregabalin capsule; and Memantine Hydrochloride tablets and Pioglitazone tablets USP. Hainan Shuangcheng Pharmaceuticals Co., Ltd. was founded in 2000 and is headquartered in Haikou, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002693.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
